Sign In   |   Register
Young Investigator Awards for Outstanding Publications 2017

Nominations - open until February 01, 2018

These annual EAS prizes for young scientists are intended to recognize distinction shown by publications that contribute to the advancement of knowledge in the field of atherosclerosis and linked metabolic disturbances.

The recipient will receive a prize of € 2000 and will present their work at the annual EAS Congress 2018 in Lisbon, Portugal during the "Rising Stars session".

These annual EAS prizes for young scientists are intended to recognize distinction shown by publications that contribute to the advancement of knowledge in the field of atherosclerosis and linked metabolic disturbances.

Nomination procedures

  • Nominations to be made by completing the nomination form (open to EAS members only)
  • Deadline for receipt of nominations is February 01, 2018.
  • The nomination should be made by an EAS member (i.e., who has paid their annual membership subscription for year 2017).
  • The nominated article should have been published January 01-December 31, 2017, and be in English.
  • The person nominated must be 40 years or younger on December 31, 2017.
  • You may nominate yourself.
  • The nominations will be reviewed by the Society's Award Committee.
  • The selection of the Award recipients is at the discretion of the Society's Executive Committee.
  • Results will be announced by March 01,2018.

To the nomination form >>

Please note that the nominator should be and EAS member and log in to access the nomination form via the link above. The nominee does not need to be an EAS member.


Recipients of the EAS Young Investigator Awards for Outstanding Publications, 2016

Paolo Zanoni, Zurich, Switzerland - for the publication “Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease” published in Science.
Science2016;351:1166-71.doi:10.1126/science.aad3517.Science

 

Pirkka-Pekka Laurila, Helsinki, Finland - for the publication “USF1 deficiency activates brown adipose tissue and improves cardiometabolic health” published in Science Translational Medicine.
Sci Transl Med. 2016 Jan 27;8(323):323ra13. doi: 10.1126/scitranslmed.aad0015

 
Membership Software Powered by YourMembership  ::  Legal